Loading...
XTSXADK
Market cap23mUSD
Jan 08, Last price  
0.35CAD
1D
9.38%
1Q
4.48%
Jan 2017
-73.08%
Name

Diagnos Inc

Chart & Performance

D1W1MN
XTSX:ADK chart
P/E
—
P/S
195.71
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
31.05%
Rev. gr., 5y
-12.22%
Revenues
170k
-61.22%
111,746709,187775,7201,863,1761,885,956358,0731,074,5131,327,8201,508,9072,704,974564,175981,4802,390,0511,612,821326,469326,469331,517267,073438,833170,158
Net income
-3m
L+19.64%
-1,746,088-581,864-617,133-398,085-2,079,903-1,910,838-1,074,271-2,192,979-2,043,717-1,640,784-2,827,588-3,192,431-5,420,641-2,897,165-3,839,056-3,839,056-3,382,873-2,051,303-2,608,218-3,120,582
CFO
-2m
L+5.37%
-1,818,447-1,236,112-876,299-547-1,747,464-1,506,911-1,408,841-1,906,675-2,008,399-1,213,753-2,866,405-2,233,132-1,786,903-2,243,595-2,319,721-2,319,721-2,640,705-1,356,799-2,037,943-2,147,432
Earnings
Feb 26, 2025

Profile

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
URL
https://www.diagnos.com/
IPO date
Sep 27, 2000
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
170
-61.22%
439
64.31%
267
-19.44%
Cost of revenue
1,217
857
615
Unusual Expense (Income)
NOPBT
(1,046)
(418)
(348)
NOPBT Margin
Operating Taxes
1
154
296
Tax Rate
NOPAT
(1,046)
(572)
(644)
Net income
(3,121)
19.64%
(2,608)
27.15%
(2,051)
-39.36%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,636
724
1,107
BB yield
-9.56%
-2.97%
-6.44%
Debt
Debt current
1,092
190
204
Long-term debt
2,358
1,225
576
Deferred revenue
Other long-term liabilities
Net debt
3,230
494
(613)
Cash flow
Cash from operating activities
(2,147)
(2,038)
(1,357)
CAPEX
(11)
(31)
(42)
Cash from investing activities
(14)
504
263
Cash from financing activities
2,084
1,596
883
FCF
(927)
(497)
(718)
Balance
Cash
219
921
1,361
Long term investments
32
Excess cash
211
899
1,379
Stockholders' equity
(3,052)
(114)
1,132
Invested Capital
3,186
1,186
472
ROIC
ROCE
EV
Common stock shares outstanding
72,822
69,617
68,735
Price
0.24
-32.86%
0.35
40.00%
0.25
-53.70%
Market cap
17,113
-29.77%
24,366
41.80%
17,184
-49.58%
EV
20,344
24,860
16,570
EBITDA
(922)
(312)
(260)
EV/EBITDA
Interest
550
54
32
Interest/NOPBT